Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
BioGill
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Provider of wastewater treatment services using eficient bioreactors

Founded in 2009
Founded in

Company type Private Public ()
Company type

Industry Group

Sector

TRL Range 9
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Australia Milwaukee, Australia
Address
City
State
Zip
Country

Parent Companies

Website

Updated by Elizabeth Lette at BioGill on 10/28/2018

Edited by Cleantech Group on 08/03/2021

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company

The Coastal Brewing Company The Coastal Brewing Company

The Coastal Brewing Company located in Forster, Australia, had to reduce BOD in its wastewater to meet local regulations. In 2017, the brewery installed a treatment system using two BioGill Towers to treat wastewater in excess of 4,000mg/L BOD to below 600mg/L BOD. Sampling results have since shown an effluent average of 249mg/L BOD with the best recorded reduction at 26mg/L BOD.

Confirmed by The Coastal Brewing Company
Delete
Partnerships
Save
Add Partnership
Date Partner Type
06/01/2016
Dow Chemical Dow Chemical
Distributor of BioGill product for specific application within the USA & China.
View source    
Confirmed by Dow Chemical
Channel Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Cancel Save
Add Investment
Date Investors Type Amount
08/17/2016 Softbank China Venture Capital (SBCVC) Softbank China Venture Capital (SBCVC) , Southern Cross Venture Partners Southern Cross Venture Partners (2)
Post-money valuation of
BioGill has received its largest capital injection to date from Softbank China Venture Capital and Southern Cross Venture Partners. The funding will be used to establish BioGill's operations in North America and China and to continue successful partnerships with multinational end-users of the technology as well as key Distributors.
 Growth Equity
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics

BioGill Ultra

A complete "plug & play" containerized biological treatment system. Largest capacity bioreactor in the BioGill range. Comes complete with control system, PLC, HMI, pumps, pH adjustment and hydraulic skid.
$/kW (current)
$/kW (projected)
$/kWh (current)
$/kWh (projected)
Delete
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font